Christoph Driessen

11.4k total citations · 1 hit paper
144 papers, 5.8k citations indexed

About

Christoph Driessen is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Christoph Driessen has authored 144 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 54 papers in Hematology and 48 papers in Oncology. Recurrent topics in Christoph Driessen's work include Multiple Myeloma Research and Treatments (50 papers), Ubiquitin and proteasome pathways (39 papers) and Peptidase Inhibition and Analysis (28 papers). Christoph Driessen is often cited by papers focused on Multiple Myeloma Research and Treatments (50 papers), Ubiquitin and proteasome pathways (39 papers) and Peptidase Inhibition and Analysis (28 papers). Christoph Driessen collaborates with scholars based in Switzerland, Germany and Netherlands. Christoph Driessen's co-authors include Marianne Kraus, Herman S. Overkleeft, Hubert Kalbacher, Hidde L. Ploegh, Lothar Rink, Michael Reich, Harold A. Chapman, Guo‐Ping Shi, Ana‐Maria Lennon‐Duménil and Ekkehard Weber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Christoph Driessen

131 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

2005 504 citations Jörn Dengjel, Oliver Schoor et al. Proceedings of the National Academy of Sciences profile →

Peers

Christoph Driessen

ONCOL

IMMUN

HEMAT

Kohsuke Imai Japan

Nathalie Droin France

Jamie I. Fletcher Australia

Albert Deisseroth United States

Salvatore Venuta Italy

Janet Plescia United States

Grover C. Bagby United States

Vivien R. Sutton Australia

Alice Mui Canada

HP Koeffler United States

Kohsuke Imai Japan

Christoph Driessen

3.3k ×1.1

1.0k ×0.6

ONCOL

2.4k ×1.7

IMMUN

665 ×0.5

HEMAT

760 ×1.1

Citations per year, relative to Christoph Driessen Christoph Driessen (= 1×) peers Kohsuke Imai

Countries citing papers authored by Christoph Driessen

Since Specialization

Citations

This map shows the geographic impact of Christoph Driessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Driessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Driessen more than expected).

Fields of papers citing papers by Christoph Driessen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Driessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Driessen. The network helps show where Christoph Driessen may publish in the future.

Co-authorship network of co-authors of Christoph Driessen

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Driessen. A scholar is included among the top collaborators of Christoph Driessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Driessen. Christoph Driessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Våtsveen, Thea Kristin, Andrej Bešše, Sigrid S. Skånland, et al.. (2025). Targeting proteostasis in multiple myeloma through inhibition of LTK. Leukemia. 39(9). 2237–2245. 1 indexed citations

Sedlaříková, Lenka, Marianne Kraus, Nicol Straková, et al.. (2024). HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. British Journal of Cancer. 131(5). 918–930. 2 indexed citations

Bešše, Lenka, Marianne Kraus, Andrej Bešše, Christoph Driessen, & Ignazio Tarantino. (2023). The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma. Scientific Reports. 13(1). 4411–4411. 5 indexed citations

Schulze, Tobias, Piero Giansanti, Lenka Bešše, et al.. (2023). Regulation of BCMA By the Ubiquitin Proteasome System Enables Optimization of BCMA-Targeting Therapies in Multiple Myeloma. Blood. 142(Supplement 1). 3310–3310. 3 indexed citations

Schlaeppi, Marc, Stephanie Roll, Petra Voiß, et al.. (2023). Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial. BMJ Open. 13(3). e066137–e066137. 2 indexed citations

Lin, Yu-Hsiu T., Gregory P. Way, Benjamin G. Barwick, et al.. (2019). Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma. Blood Advances. 3(21). 3214–3227. 14 indexed citations

Brünnert, Daniela, Marianne Kraus, Thorsten Stühmer, et al.. (2019). Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1666–1676. 13 indexed citations

Amodio, Nicola, Maria Eugenia Gallo Cantafio, Cirino Botta, et al.. (2019). Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers. 11(2). 236–236. 35 indexed citations

Xin, Bo‐Tao, E.M. Huber, Gerjan de Bruin, et al.. (2019). Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. Journal of Medicinal Chemistry. 62(3). 1626–1642. 28 indexed citations

10.

Bešše, Andrej, Lenka Bešše, Sara Christina Stolze, et al.. (2017). Nelfinavir Blocks Export of Newly Synthesized Protein from the ER and Interacts with ER-Resident and Mitochondrial Proteins in an Activity-Dependent Fashion. Blood. 130. 3074–3074. 1 indexed citations

11.

Abt, Dominik, Andrej Bešše, Lenka Sedlaříková, et al.. (2017). Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus ( HIV )‐protease inhibitors lopinavir or nelfinavir. British Journal of Urology. 121(4). 600–609. 11 indexed citations

12.

Yong, Kwee, Michel Delforge, Christoph Driessen, et al.. (2015). MULTIPLE MYELOMA MANAGEMENT: OUTCOMES IN REAL-WORLD PRACTICE. Haematologica. 100. 252–253. 1 indexed citations

13.

Raab, Marc‐Steffen, Michèle Cavo, Michel Delforge, et al.. (2015). MULTIPLE MYELOMA MANAGEMENT: PRACTICE PATTERNS ACROSS EUROPE. Haematologica. 100. 251–252. 3 indexed citations

14.

Arastu‐Kapur, Shirin, Janet L. Anderl, Marianne Kraus, et al.. (2011). Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events. Clinical Cancer Research. 17(9). 2734–2743. 329 indexed citations

15.

Stoeckle, Christina, Eleni Adamopoulou, Stephan Schiekofer, et al.. (2008). Cathepsin G is differentially expressed in primary human antigen-presenting cells. Cellular Immunology. 255(1-2). 41–45. 23 indexed citations

16.

Zaidi, Nousheen, Timo Burster, Bernhard O. Boehm, et al.. (2007). A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A. Biochemical and Biophysical Research Communications. 364(2). 243–249. 31 indexed citations

17.

Dengjel, Jörn, Oliver Schoor, Rainer Fischer, et al.. (2005). Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proceedings of the National Academy of Sciences. 102(22). 7922–7927. 504 indexed citations breakdown →

18.

Burster, Timo, Alexander Beck, Eva Tolosa, et al.. (2005). Differential Processing of Autoantigens in Lysosomes from Human Monocyte-Derived and Peripheral Blood Dendritic Cells. The Journal of Immunology. 175(9). 5940–5949. 41 indexed citations

19.

Burster, Timo, Alexander Beck, Eva Tolosa, et al.. (2004). Cathepsin G, and Not the Asparagine-Specific Endoprotease, Controls the Processing of Myelin Basic Protein in Lysosomes from Human B Lymphocytes. The Journal of Immunology. 172(9). 5495–5503. 63 indexed citations

20.

Tolosa, Eva, Weijie Li, Yoshiyuki Yasuda, et al.. (2003). Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. Journal of Clinical Investigation. 112(4). 517–526. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact